Summary
WiseGuyReports.com adds “Argatroban Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022” reports to its database.
This report provides in depth study of “Argatroban Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Argatroban Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Global and Regional Argatroban market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Pfizer
SANDOZ
GlaxoSmithKline
fresenius-kabi
Eagle Pharmaceuticals
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries
WEST-WARD
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2435916-global-and-regional-argatroban-market-research-report-2017
Market Segment as follows:
By Region
Asia-Pacific
North America
Europe
South America
Middle East & Africa
By Type
Argatroban Powder
Argatroban Injection
By Application
Heparin-induced thrombocytopenia (HIT)
Percutaneous Coronary Intervention
Cerebral arterial thrombosis
At any Query @ https://www.wiseguyreports.com/enquiry/2435916-global-and-regional-argatroban-market-research-report-2017
Table of Contents
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Argatroban Powder
1.1.2.2 Argatroban Injection
1.1.3 Market by Application
1.1.3.1 Heparin-induced thrombocytopenia (HIT)
1.1.3.2 Percutaneous Coronary Intervention
1.1.3.3 Cerebral arterial thrombosis
1.2 Global and Regional Market Size
1.2.1 Global Overview
1.2.2 Market by Region
1.2.2.1 Asia-Pacific
1.2.2.2 North America
1.2.2.3 Europe
1.2.2.4 South America
1.2.2.5 Middle East & Africa
….
6 Key Manufacturers
6.1 Pfizer
6.1.2 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 SANDOZ
6.2.1 Company Information
6.2.2 Product Specifications
6.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.3 GlaxoSmithKline
6.3.1 Company Information
6.3.2 Product Specifications
6.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.4 fresenius-kabi
6.4.1 Company Information
6.4.2 Product Specifications
6.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.5 Eagle Pharmaceuticals
6.5.1 Company Information
6.5.2 Product Specifications
6.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.6 Mitsubishi Tanabe Pharma
6.6.1 Company Information
6.6.2 Product Specifications
6.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.7 Teva Pharmaceutical Industries
6.7.1 Company Information
6.7.2 Product Specifications
6.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.8 WEST-WARD
6.8.1 Company Information
6.8.2 Product Specifications
6.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2435916
Continued….
Contact Us: sales@wiseguyreports.com
Ph: +1-646-845-9349 (US) ; Ph: +44 208 133 9349 (UK)